International Trade

President Trump Strengthens U.S. Policy Toward Cuba

Did you know that the Department of the Treasury’s Office of Foreign Assets Control (OFAC) announced additional changes to U.S. policy toward Cuba implemented on October 9? On September 6th, the Trump Administration announced measures to increase economic pressure on the Cuban military regime. This follows past policy changes President Trump has taken to sanction the Cuban government for its daily human rights abuses against the Cuban people and abroad. Earlier this year, the President restricted non-family travel to Cuba by removing the travel exemption category of “people-to-people” travel to the island. 

[…]

U.S. Expands Trade War to EU

After winning the largest arbitration award (7.5 billion) in World Trade Organization (WTO) history in its dispute with the European Union (EU) over illegal subsidies to Airbus, the United States (US) will begin applying WTO-approved tariffs on certain EU goods beginning October 18. Although USTR has the authority to apply a 100 percent tariff on affected products, at this time the tariff increases will be limited to 10% on large civil aircrafts and 25% on agricultural and other products. The U.S. has the authority to increase the tariffs at any time, or change the products affected.

[…]

New FTC Warning Letters Issued to Companies Selling CBD Products

blog p1

The United States Federal Trade Commission (FTC) issued a press release confirming is sent three warning letters to companies that sell oils, tinctures, capsules, “gummies,” and creams containing cannabidiol (CBD), a chemical compound derived from the cannabis plant. While the warning letters are not made publicly available, the FTC advised the warning letters were sent because the companies were advertising their CBD products could treat or cure serious diseases and health conditions, in violation of both the FTC Act (as well as U.S. Food and Drug Administration (FDA)) laws and regulations.

[…]

Here are the Major Changes FDA is Proposing to Make to the Sunscreen Rule!

On February 26 2019, the United States Food and Drug Administration (FDA) proposed a rule that would alter the regulations associated with the manufacturing and selling of sunscreen, as well as other sun-care related products. Since the closing of the comment period on May 28th, 2019, FDA has received over one thousand comments from industry players voicing their concern over various aspects of the proposed measures.

The proposed rule was issued as part of the regulatory proceeding to put into effect a final monograph for nonprescription, OTC sunscreen drug products under the OTC Drug Review. An OTC monograph establishes conditions under which certain OTC drugs may be marketed without approved new drug applications because they are generally recognized as safe and effective (GRASE) and not misbranded. The proposed rule classifies active ingredients and other conditions as:

[…]

India removed from GSP, potential problems permeate

After the Trump Administration officially revoked India’s participation in the Generalized System of Preference (GSP) on June 5, 2019, India announced that it intends to implement tariffs on roughly 30 HTS-listed items. The items-which include many agricultural goods, such as almonds and apples- would be subjected to 70% duties upon entry.

[…]

Go to Top